// App-Quantinova.ai

e16525 : Prospective, non-interventional study on the influence of adherence measures on the therapy with abiraterone acetate (AA) + prednisone/prednisolone (P) in patients with metastatic, castration resistant prostate carcinoma.

Researchers

Presenter

  • Henrik Suttmann

Principal Investigators

  • Susan Feyerabend

  • Jochen Gleissner

  • Andreas Huebner

  • Edmund A.M. Neugebauer

  • Tim Mathes

  • Werner Baurecht

  • Natasha Schuier

Medical Centers

  • Urologikum Hamburg, Hamburg, Germany

  • Studienpraxis Urologie, Nurtingen, Germany

  • Urologie in der Hofaue, Wuppertal, Germany

  • Wissenschaftskontor Nord, Rostock, Germany

  • Institute for Research in Operative Medicine, Cologne, Germany

  • acromion GmbH, Biometrics, Frechen, Germany

  • Janssen-Cilag GmbH, Neuss, Germany

Locations

  • Germany

Companies

  • JB Medical Ltd.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

  • Prednisolone

  • Prednisone

Outcome

  • Unknown

Study Design

  • Non Interventional

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved